Search Results

Pharmacogenetic Influence on Stereoselective Steady-State Disposition of Bupropion.

• Authors : Kharasch ED; Department of Anesthesiology, Duke University, Durham, North Carolina (E.D.K.); Bermaride, LLC (E.D.K.)

Subjects: Bupropion*/Bupropion*/Bupropion*/*analogs & derivatives; Bupropion*/Bupropion*/Bupropion*/pharmacokinetics ; Depressive Disorder, Major*

• Source: Drug metabolism and disposition: the biological fate of chemicals [Drug Metab Dispos] 2024 Apr 16; Vol. 52 (5), pp. 455-466. Date of Electronic Publication: 2024 Apr 16.Publisher: American Society for Pharmacology and Experimental Therapeutics, etc.] Country of Publication: United States NLM ID: 9421550 Publication Model:

Record details

Addendum: Bupropion safety in pregnancy.

Subjects: Bupropion*/Bupropion*/Bupropion*/adverse effects ; Smoking Cessation*; Pregnancy

• Source: The Medical letter on drugs and therapeutics [Med Lett Drugs Ther] 2024 Apr 01; Vol. 66 (1699), pp. 56.Publisher: The Medical Letter Country of Publication: United States NLM ID: 2985240R Publication Model: Print Cited Medium: Internet ISSN:

Record details

Changes in lipid profile and glucose metabolism following administration of bupropion alone or in combination with naltrexone: A systematic review and meta-regression analysis.

• Authors : Hu Y; School of Pharmacy, China Pharmaceutical University, Nanjing, China.; Velu P

Subjects: Bupropion* ; Naltrexone*/Naltrexone*/Naltrexone*/pharmacology; Humans

• Source: European journal of clinical investigation [Eur J Clin Invest] 2024 Apr; Vol. 54 (4), pp. e14122. Date of Electronic Publication: 2023 Nov 06.Publisher: Wiley Country of Publication: England NLM ID: 0245331 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2362

Record details

Update Lessons from PET Imaging Part II: A Systematic Critical Review on Therapeutic Plasma Concentrations of Antidepressants.

• Authors : Hart XM; Department of Molecular Neuroimaging, Central Institute of Mental Health, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.; Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan

Subjects: Selective Serotonin Reuptake Inhibitors* ; Bupropion*/Bupropion*/Bupropion*/therapeutic use; Humans

• Source: Therapeutic drug monitoring [Ther Drug Monit] 2024 Apr 01; Vol. 46 (2), pp. 155-169. Date of Electronic Publication: 2024 Jan 24.Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 7909660 Publication Model: Print-Electronic Cited Medium:

Record details

Effects of pre-gestational exposure to the stressors and perinatal bupropion administration on the firing activity of serotonergic neurons and anxiety-like behavior in rats.

• Authors : Grinchii D; Institute of Molecular Physiology and Genetics, Centre of Biosciences, Slovak Academy of Sciences, Bratislava, Slovakia. Electronic address: .; Janáková Csatlósová K

Subjects: Bupropion*/Bupropion*/Bupropion*/pharmacology ; Serotonergic Neurons*; Humans

• Source: Behavioural brain research [Behav Brain Res] 2024 Feb 29; Vol. 459, pp. 114796. Date of Electronic Publication: 2023 Dec 02.Publisher: Elsevier/North-Holland Biomedical Press Country of Publication: Netherlands NLM ID: 8004872 Publication Model: Print-Electronic Cited Medium:

Record details

Multidimensional assessment of adverse events of bupropion: A large-scale data analysis from the FAERS database.

• Authors : Lu R; Mental Health Center of Jiangnan University, Wuxi Central Rehabilitation Hospital, Wuxi, Jiangsu 214151, China.; Jiang Y

Subjects: Bupropion*/Bupropion*/Bupropion*/adverse effects ; Smoking Cessation*/Smoking Cessation*/Smoking Cessation*/psychology; Infant, Newborn

• Source: Journal of affective disorders [J Affect Disord] 2024 Jun 01; Vol. 354, pp. 649-655. Date of Electronic Publication: 2024 Mar 15.Publisher: Elsevier/North-Holland Biomedical Press Country of Publication: Netherlands NLM ID: 7906073 Publication Model: Print-Electronic Cited Medium:

Record details

Uncoupling of Cytochrome P450 2B6 and stimulation of reactive oxygen species production in pharmacogenomic alleles affected by interethnic variability.

• Authors : Yamoune S; Institute of Clinical Pharmacology, University Hospital of RWTH Aachen, Germany; Research Division, Federal Institute for Drugs and Medical Devices (BfArM), Bonn, Germany. Electronic address: .

Subjects: Bupropion*/Bupropion*/Bupropion*/metabolism ; Bupropion*/Bupropion*/Bupropion*/pharmacology ; Cytochrome P-450 CYP2B6*/Cytochrome P-450 CYP2B6*/Cytochrome P-450 CYP2B6*/drug effects

• Source: Biochimica et biophysica acta. General subjects [Biochim Biophys Acta Gen Subj] 2024 May; Vol. 1868 (5), pp. 130595. Date of Electronic Publication: 2024 Mar 10.Publisher: Elsevier Country of Publication: Netherlands NLM ID: 101731726 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Quantitation of Bupropion in Urine by Liquid Chromatography-Tandem Mass Spectrometry.

• Authors : Li X; Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA, USA.; Plotkina N

Subjects: Bupropion* ; Tandem Mass Spectrometry*/Tandem Mass Spectrometry*/Tandem Mass Spectrometry*/methods; Humans

• Source: Methods in molecular biology (Clifton, N.J.) [Methods Mol Biol] 2024; Vol. 2737, pp. 113-121.Publisher: Humana Press Country of Publication: United States NLM ID: 9214969 Publication Model: Print Cited Medium: Internet ISSN: 1940-6029

Record details

Bupropion for treatment of amphetamine-type stimulant use disorder: A systematic review and meta-analysis of placebo-controlled randomized clinical trials.

• Authors : Bakouni H; Research Centre, Centre Hospitalier de l'Université de Montréal (CRCHUM), Montréal, Québec, Canada; Department of Psychiatry and Addictology, Faculty of Medicine, Université de Montréal, Montréal, Québec, Canada.

Subjects: Bupropion*/Bupropion*/Bupropion*/adverse effects ; Substance-Related Disorders*/Substance-Related Disorders*/Substance-Related Disorders*/drug therapy; Male

• Source: Drug and alcohol dependence [Drug Alcohol Depend] 2023 Dec 01; Vol. 253, pp. 111018. Date of Electronic Publication: 2023 Nov 04.Publisher: Elsevier Country of Publication: Ireland NLM ID: 7513587 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0046

Record details

Increased depression-like behaviors with altered brain dopamine metabolisms in male mice housed in large cages are alleviated by bupropion.

• Authors : Kurogi K; Laboratory of Regulation in Metabolism and Behavior, Faculty of Agriculture, Kyushu University, 744 Motooka, Nishi-ku, Fukuoka, 819-0395, Japan.; Taniguchi F

Subjects: Bupropion*/Bupropion*/Bupropion*/pharmacology ; Dopamine*/Dopamine*/Dopamine*/metabolism; Female

• Source: European journal of pharmacology [Eur J Pharmacol] 2023 Dec 05; Vol. 960, pp. 176126. Date of Electronic Publication: 2023 Oct 17.Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 1254354 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details